Company Presentation

AdRegeneer develops regenerative treatments for the nervous system to repair lesions due to a traumatic injury or in the context of a neurodegenerative disease. To this aim, we apply a new paradigm using epigenetic factors and gene therapy that induce the repair program in neural cells. Our most advanced drug is ready for GMP production and clinical trials on multiple sclerosis patients. In addition, we have a pipeline of several additional drugs currently under development.